APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,022,557 | +6.7% | 1,788,185 | +155.6% | 0.01% | +7.7% |
| Q2 2023 | $63,743,581 | +24.5% | 699,710 | -9.9% | 0.01% | +18.2% |
| Q1 2023 | $51,211,080 | +125.8% | 776,396 | +77.0% | 0.01% | +120.0% |
| Q4 2022 | $22,676,490 | -11.1% | 438,532 | +17.4% | 0.01% | -28.6% |
| Q3 2022 | $25,521,000 | +261.1% | 373,660 | +139.1% | 0.01% | +250.0% |
| Q2 2022 | $7,067,000 | -64.5% | 156,280 | -60.1% | 0.00% | -50.0% |
| Q1 2022 | $19,919,000 | -5.8% | 392,035 | -12.4% | 0.00% | – |
| Q4 2021 | $21,156,000 | -53.7% | 447,498 | -67.7% | 0.00% | -100.0% |
| Q3 2021 | $45,725,000 | -26.2% | 1,387,310 | +41.5% | 0.01% | -37.5% |
| Q2 2021 | $61,966,000 | +498.4% | 980,469 | +306.3% | 0.01% | +300.0% |
| Q1 2021 | $10,355,000 | -47.4% | 241,323 | -29.8% | 0.00% | 0.0% |
| Q4 2020 | $19,670,000 | +308.1% | 343,880 | +115.3% | 0.00% | – |
| Q3 2020 | $4,820,000 | -31.7% | 159,743 | -26.1% | 0.00% | -100.0% |
| Q2 2020 | $7,057,000 | -14.7% | 216,061 | -30.0% | 0.00% | 0.0% |
| Q1 2020 | $8,272,000 | -34.5% | 308,794 | -25.1% | 0.00% | -33.3% |
| Q4 2019 | $12,629,000 | +240.1% | 412,432 | +167.5% | 0.00% | +50.0% |
| Q3 2019 | $3,713,000 | +109.5% | 154,198 | +120.4% | 0.00% | – |
| Q2 2019 | $1,772,000 | – | 69,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |